Abstract
Cardiopulmonary exercise testing (CPET) in pediatric patients differs in many aspects from the tests as performed in adults. Childrens cardiopulmonary responses during exercise testing present different characteristics, particularly indices of respiratory gas exchange (e.g. oxygen uptake, ventilation and ventilatory efficiency), which are essential in interpreting hemodynamic data. Diseases that are associated with myocardial ischemia are very rare in children. Important indications for CPET in children are the evaluation of exercise capacity and the non-invasive identification of pathologic features. In this article we will review the methodology, and clinical concepts exercise testing and interpretation of respiratory gas-exchange during exercise in children with congenital heart disease.
Keywords: VO2max, exercise testing, exercise physiology, oxygen uptake, Congenital Heart Disease, Cardiopulmonary exercise testing, ventilatory efficiency, myocardial ischemia, prognostic markers, children's cardiopulmonary responses, pulmonary hypertension, Ergometers
Related eBooks
Related Articles
-
Effects of Tea Catechins on Inflammation-Related Cardiovascular Diseases
Current Immunology Reviews ATP-Sensitive K+ Channel Openers: Old Drugs with New Clinical Benefits for the Heart
Current Vascular Pharmacology New Insights in Research About Acute Ischemic Myocardial Injury and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Effect of β-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery
Current Drug Targets The Influence of Obese Insulin-Resistance on the Outcome of the Ischemia/Reperfusion Insult to the Heart
Current Medicinal Chemistry Cardiac Metabolism in Myocardial Ischemia
Current Pharmaceutical Design Bradykinin is Involved in the Mediation of Cardiac Nociception during Ischemia through Upper Thoracic Spinal Neurons
Current Neurovascular Research Targeting Cardiac Mast Cells: Pharmacological Modulation of the Local Renin-Angiotensin System
Current Pharmaceutical Design How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with the Metabolic Syndrome?
Vascular Disease Prevention Considerations in Understanding the Coronary Blood Flow- Left Ventricular Mass Relationship in Patients with Hypertension
Current Cardiology Reviews Poly(ADP-Ribose) Polymerase Inhibitors
Current Medicinal Chemistry The Mast Cell: A Potential Therapeutic Target in Myocardial Infarction
Drug Design Reviews - Online (Discontinued) Myocardial Energetics in Left Ventricular Hypertrophy
Current Cardiology Reviews Ivabradine: a Selective If Current Inhibitor in the Treatment of Stable Angina
Recent Patents on Cardiovascular Drug Discovery (Discontinued) NTproBNP: An Important Biomarker in Cardiac Diseases
Current Topics in Medicinal Chemistry The Role of Hydrogen Sulfide and H2S-donors in Myocardial Protection Against Ischemia/Reperfusion Injury
Current Medicinal Chemistry Improving RBC K Transport and Hemoglobin-O2 Binding by Amiloride: A Novel Therapeutic Approach for Reversion of Angina and Myocardial Ischemia in Coronary Heart Diseases
Recent Patents on Cardiovascular Drug Discovery (Discontinued) Cardioprotection by Regular Ethanol Consumption: Potential Mechanisms and Clinical Application
Current Drug Abuse Reviews Connexin43 and Myocardial Ischemia-Reperfusion Injury
Cardiovascular & Hematological Disorders-Drug Targets Gallium-68 Based Positron Emission Tomography (PET) Probes for Myocardial Perfusion Imaging
Current Medical Imaging